BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 10647650)

  • 1. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.
    Fergany AF; Hafez KS; Novick AC
    J Urol; 2000 Feb; 163(2):442-5. PubMed ID: 10647650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    Hafez KS; Novick AC; Campbell SC
    J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
    Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
    Hafez KS; Novick AC; Butler BP
    J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients.
    Lapini A; Serni S; Minervini A; Masieri L; Carini M
    J Urol; 2005 Jul; 174(1):57-60; discussion 60. PubMed ID: 15947577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Year outcomes of laparoscopic partial nephrectomy.
    Lane BR; Gill IS
    J Urol; 2007 Jan; 177(1):70-4; discussion 74. PubMed ID: 17162003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome.
    Allaf ME; Bhayani SB; Rogers C; Varkarakis I; Link RE; Inagaki T; Jarrett TW; Kavoussi LR
    J Urol; 2004 Sep; 172(3):871-3. PubMed ID: 15310986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron sparing surgery for central renal tumors: experience with 33 cases.
    Black P; Filipas D; Fichtner J; Hohenfellner R; Thüroff JW
    J Urol; 2000 Mar; 163(3):737-43. PubMed ID: 10687967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephron sparing surgery for renal tumors: indications, techniques and outcomes.
    Uzzo RG; Novick AC
    J Urol; 2001 Jul; 166(1):6-18. PubMed ID: 11435813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.